Trial intelligence / Profile preview

PK of FE 999303 (Testosterone Gel) Applicator vs Hand in Hypogonadal Males

NCT01464879Phase 2Completed

Sponsor
Ferring Pharmaceuticals
Start
Dec 2011
Primary completion
May 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Testosterone TEPI patch in Hypogonadism, sponsored by Ferring Pharmaceuticals. Started Dec 2011; status: completed.

02

Drugs

Testosterone TEPI patch
03

Conditions

Hypogonadism

Beyond the preview

Go deeper on NCT01464879.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01464879.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call